ASPEN PHARMACARE HOLDINGS LIMITED - Reminder of the Release of Interim Results for the six months ended 31 December 2023 and a Live Presentation Thereof

Reminder of the Release of Interim Results for the six months ended 31 December 2023 and a Live Presentation Thereof

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")

REMINDER OF THE RELEASE OF ASPEN'S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31st DECEMBER
2023 AND A LIVE PRESENTATION THEREOF

Shareholders are advised that Aspen intends releasing its results for the six months ended 31st December
2023 on Monday, 4th March 2024 on SENS at 13:00pm (SAST, GMT+2) with a presentation to members of the
investment community in-person at the Bank of America Sun City conference and via webcast on Tuesday,
5th March 2024 at 08:30am (SAST, GMT+2).

All interested stakeholders are invited to watch the live webcast which can be accessed using the following
link: https://www.corpcam.com/Aspen05032024. In-person attendees are requested to RSVP using the
following link: https://aspenpharmaforms.com/view.php?id=31392.

The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com)
from the home page shortly before the commencement of the presentation on Tuesday, 5th March 2024.

A playback of the webcast will be made available on our website approximately 2 hours after the
presentation.

Durban
27 February 2024

Sponsor:
Investec Bank Limited

Date: 27-02-2024 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.